Welcome to our dedicated page for Marketaxess Hldgs SEC filings (Ticker: MKTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Digging through MarketAxess’s SEC filings can feel like parsing an entire bond prospectus—trading-volume tables, algorithm disclosures and fee schedules are scattered across hundreds of pages. If you have ever wondered, “How do I find MarketAxess insider trading Form 4 transactions?” or “Where is the latest MarketAxess quarterly earnings report 10-Q filing?,” you are not alone.
Stock Titan solves that problem. Our AI quickly turns the labyrinth of exhibits into plain language, giving you MarketAxess SEC filings explained simply. Receive real-time alerts the instant a MarketAxess Form 4 insider transactions real-time notice lands in EDGAR, scan an interactive dashboard that links revenue per million traded to segment growth, and jump straight to footnotes on platform uptime—all without opening a PDF.
- 10-K: MarketAxess annual report 10-K simplified with AI-generated commentary on trading-fee yields and technology spending.
- 10-Q: Side-by-side MarketAxess earnings report filing analysis to track quarter-over-quarter bond-volume trends.
- 8-K: MarketAxess 8-K material events explained, from regulatory shifts to major system enhancements.
- DEF 14A: Deep dive into the MarketAxess proxy statement executive compensation structure.
- Form 4: Monitor MarketAxess executive stock transactions Form 4 to gauge insider sentiment.
Whether you’re understanding MarketAxess SEC documents with AI ahead of a rate decision or benchmarking fee capture against peers, Stock Titan provides comprehensive coverage, AI-powered summaries and real-time updates that let fixed-income professionals make decisions faster.
Thermo Fisher Scientific Inc. (TMO) filed a Form 4 on July 1, 2025 disclosing that director Jennifer M. Johnson was credited with 76.54 phantom stock units on June 28, 2025 under the company’s Deferred Compensation Plan for Directors. The units, valued at $408.28 each, convert to common stock on a 1-for-1 basis when the director leaves the board or upon a change of control. After the credit, Johnson holds 474.05 stock-equivalent units, all recorded as direct ownership.
The transaction represents routine deferral of quarterly board retainer fees rather than an open-market purchase or sale. With an estimated market value of roughly $31 thousand, the filing is financially immaterial relative to Thermo Fisher’s multi-billion-dollar market capitalization. No options were exercised, no common shares were sold, and the company’s share count and cash position remain unchanged. The filing nevertheless reinforces incentive alignment by tying a portion of Johnson’s compensation to future shareholder returns.
FAQ
What is the current stock price of Marketaxess Hldgs (MKTX)?
What is the market cap of Marketaxess Hldgs (MKTX)?
What is the core business model of MarketAxess?
How does MarketAxess facilitate electronic trading?
Which types of fixed-income securities are traded on its platform?
What distinguishes MarketAxess from traditional trading platforms?
How does MarketAxess support market participants beyond trade execution?
How is MarketAxess positioned within the competitive landscape?
